ArticleFrontiers in immunology2026
Clinical exploration of first-line therapy in metastatic lung adenocarcinoma patients with negative or low PD-L1 expression: a retrospective cohort study.
Kun Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.